These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10715144)

  • 1. Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity.
    Nan F; Bzdega T; Pshenichkin S; Wroblewski JT; Wroblewska B; Neale JH; Kozikowski AP
    J Med Chem; 2000 Mar; 43(5):772-4. PubMed ID: 10715144
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
    Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
    J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.
    Jackson PF; Tays KL; Maclin KM; Ko YS; Li W; Vitharana D; Tsukamoto T; Stoermer D; Lu XC; Wozniak K; Slusher BS
    J Med Chem; 2001 Nov; 44(24):4170-5. PubMed ID: 11708918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
    Majer P; Jackson PF; Delahanty G; Grella BS; Ko YS; Li W; Liu Q; Maclin KM; Poláková J; Shaffer KA; Stoermer D; Vitharana D; Wang EY; Zakrzewski A; Rojas C; Slusher BS; Wozniak KM; Burak E; Limsakun T; Tsukamoto T
    J Med Chem; 2003 May; 46(10):1989-96. PubMed ID: 12723961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiospecificity of glutamate carboxypeptidase II inhibition.
    Tsukamoto T; Majer P; Vitharana D; Ni C; Hin B; Lu XC; Thomas AG; Wozniak KM; Calvin DC; Wu Y; Slusher BS; Scarpetti D; Bonneville GW
    J Med Chem; 2005 Apr; 48(7):2319-24. PubMed ID: 15801825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of NAALADase inhibitors: a novel neuroprotective strategy.
    Jackson PF; Slusher BS
    Curr Med Chem; 2001 Jul; 8(8):949-57. PubMed ID: 11375762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
    Lea PM; Wroblewska B; Sarvey JM; Neale JH
    J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
    Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
    J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase).
    Kozikowski AP; Nan F; Conti P; Zhang J; Ramadan E; Bzdega T; Wroblewska B; Neale JH; Pshenichkin S; Wroblewski JT
    J Med Chem; 2001 Feb; 44(3):298-301. PubMed ID: 11462970
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective antagonists at group I metabotropic glutamate receptors: synthesis and molecular pharmacology of 4-aryl-3-isoxazolol amino acids.
    Kromann H; Sløk FA; Stensbøl TB; Bräuner-Osborne H; Madsen U; Krogsgaard-Larsen P
    J Med Chem; 2002 Feb; 45(4):988-91. PubMed ID: 11831912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
    Selvam C; Oueslati N; Lemasson IA; Brabet I; Rigault D; Courtiol T; Cesarini S; Triballeau N; Bertrand HO; Goudet C; Pin JP; Acher FC
    J Med Chem; 2010 Apr; 53(7):2797-813. PubMed ID: 20218620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-(+)-2-Amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency.
    Selvam C; Goudet C; Oueslati N; Pin JP; Acher FC
    J Med Chem; 2007 Sep; 50(19):4656-64. PubMed ID: 17722902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
    Thomas AG; Olkowski JL; Slusher BS
    Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
    Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
    FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.
    Sagot E; Jensen AA; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Assaf Z; Aboab B; Bolte J; Gefflaut T; Bunch L
    J Med Chem; 2008 Jul; 51(14):4085-92. PubMed ID: 18578477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.
    Tsukamoto T; Wozniak KM; Slusher BS
    Drug Discov Today; 2007 Sep; 12(17-18):767-76. PubMed ID: 17826690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists.
    Wendt JA; Deeter SD; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5396-9. PubMed ID: 17723296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
    Lu H; Berkman CE
    Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.